page_accueil_3_actus

Articles

• Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors
  3 February, by Emmanuelle BETTENDORF

  We are excited that Jerome Berger is joining our Board of Directors!
  Jerome brings vast expertise in strategy, finance, and venture capital in the technology and life sciences sectors, which will be invaluable as Vect-Horus accelerates its growth and development.
  “Jerome’s unparalleled experience in strategy, venture capital and global financing, coupled with his strong background in digital health and life sciences, will be invaluable in supporting the development of Vect-Horus as we (…)

• mRNA Based Therapeutics poster
  3 February, by Emmanuelle BETTENDORF

  Pavlo Shpak-Kraievskyi is presenting a poster on behalf of Vect-Horus at the 4th Annual mRNA-Based Therapeutics Summit Europe, taking place January 28-30 in Frankfurt, Germany.
  Effective delivery of mRNA therapeutics to the central nervous system (CNS) remains a significant challenge due to the protective blood-brain barrier (BBB). The poster, entitled “VECTrans® Technology for CNS Targeting with Lipid Nanoparticles”, outlines results from a study of VECTrans® enabling the targeted (…)

• Poster presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
  15 May 2024, by Emmanuelle BETTENDORF

  The poster, entitled “VECTrans® technology: a powerful delivery approach to significantly enhance efficacy of therapeutic oligonucleotides in retina cells”, outlines a study assessing Vect-Horus’ proprietorial VECTrans® technology. This is based on the specific design and optimization of molecular vectors that, once joined to a payload, enable its delivery to target specific organs in the body.
  The study showed that these vectors have the potential to improve delivery of medication to the (…)

• Meet Vect-Horus at BIO Japan
  3 September 2019, by Elodie DORMES

  Dr Jamal TEMSAMANI, Drug Development and Corporate Director will attend BIO Japan from October 9–11, 2019
  If you are interested to meet, please use the B2B Partnering system.

• Vect-Horus will be attending the EANM’19 Congress in Barcelona
  3 September 2019, by Elodie DORMES

  Cedric MALICET PhD, Oncology Project Manager and Elodie DORMES, Business Development Manager will attend EANM from 12-16 October, 2019 in Barcelona to discuss Peptide Receptor Radionuclide Therapy strategy and partnered Vect-Horus’ products.

• Vect-Horus will attend BIO International Convention in PHILADELPHIA
  25 April 2019, by Elodie DORMES

  Vect-Horus will attend BIO US in Philadelphia | June 3-6, 2019.
  If you are interested to meet, please use the B2B Partnering system.

• Meet Vect-Horus at BIO Spring Vienna
  18 January 2019, by Jonathan NOWAK

  VECT-HORUS will attend BIO Europe from March 25–26, 2019
  If you are interested to meet, please use the B2B Partnering system.
  https://ebdgroup.knect365.com/bioeu...